Usage of "bortezomib"

rus

portuguès

espanyol

Chemical compound.

Termes relacionats

Ús de bortezomib en anglès

These biomarkers data begin to illuminate bortezomib's mechanism of action in lymphoma. 
 Pubmed 

Results: Thirty-one per cent of patients received bortezomib beyond first relapse. 
 Pubmed 

However, apoptotic response to bortezomib was not affected by the deletion of p53. 
 Pubmed 

Recently, it has been shown that bortezomib treatment enhances OB function. 
 Pubmed 

The safety profile was consistent with that reported for single-agent bortezomib and romidepsin. 
 Pubmed 

These data suggest that bortezomib-induced plasma cell depletion triggers humoral compensation. 
 Pubmed 

We tested the signature in independent cohorts treated with bortezomib- and lenalidomide-based therapies. 
 Pubmed 

After repeated treatment, initially sensitive lung tumors became resistant to bortezomib. 
 Pubmed 

The synergistic interaction between oHSV and bortezomib was calculated using a Chou-Talalay analysis. 
 Pubmed 

The combination of bortezomib and IFN-a can be safely administered to melanoma patients. 
 Pubmed 

The proteasome inhibitor bortezomib is an efficacious apoptotic agent in many tumor cells. 
 Pubmed 

The degree of proteasome inhibition was similar to that reported with single-agent bortezomib. 
 Pubmed 

When possible, all subsequent doses of bortezomib within each cycle were provided at home. 
 Pubmed 

Conversely, none of the patients who received a treatment without bortezomib developed muscular symptoms. 
 Pubmed 

Conclusion: Both bortezomib plus rituximab regimens seem feasible in relapsed or refractory indolent lymphomas. 
 Pubmed 

This delineates another therapeutic mechanism of bortezomib in T-cell malignancies. 
 Pubmed 

bortezomib

Nom

Singular

Col·locacions frequents

Més col·locacions

Translations for bortezomib

rus

portuguès

espanyol

Bortezomib a través del temps

Bortezomib per variant geogràfica

Estats Units d'Amèrica

Comú

Significats de bortezomib en anglès